Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ad-Free, Unlimited access)​
NO CREDIT CARD REQUIRED
COCHW
Upturn stock ratingUpturn stock rating

Envoy Medical Inc. (COCHW)

Upturn stock ratingUpturn stock rating
$0.04
Last Close (24-hour delay)
upturn advisory
PASS
  • BUY Advisory
  • SELL Advisory (Profit)​
  • SELL Advisory (Loss)​
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

06/30/2025: COCHW (1-star) is currently NOT-A-BUY. Pass it for now.

Upturn Star Rating

rating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

Number of Analysts

rating

Analysts rated it

Very few follow this stock; limited insights, higher-risk early investing.

1 Year Target Price $0

1 Year Target Price $0

Analysts Price Target For last 52 week
$0Target price
Low$
Current$0.04
high$

Analysis of Past Performance

Type Stock
Historic Profit -70%
Avg. Invested days 25
Today’s Advisory PASS
Upturn Star Rating Upturn stock ratingUpturn stock rating
Upturn Advisory Performance Upturn Advisory Performance 1.0
Stock Returns Performance Upturn Returns Performance 1.0
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 06/30/2025

Key Highlights

Company Size ETF
Market Capitalization 0 USD
Price to earnings Ratio -
1Y Target Price -
Price to earnings Ratio -
1Y Target Price -
Volume (30-day avg) -
Beta 2.27
52 Weeks Range 0.03 - 0.10
Updated Date 06/28/2025
52 Weeks Range 0.03 - 0.10
Updated Date 06/28/2025
Dividends yield (FY) -
Basic EPS (TTM) -

Earnings Date

Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin -
Operating Margin (TTM) -11102.17%

Management Effectiveness

Return on Assets (TTM) -129.07%
Return on Equity (TTM) -

Valuation

Trailing PE -
Forward PE -
Enterprise Value -
Price to Sales(TTM) -
Enterprise Value -
Price to Sales(TTM) -
Enterprise Value to Revenue -
Enterprise Value to EBITDA -
Shares Outstanding -
Shares Floating 10658404
Shares Outstanding -
Shares Floating 10658404
Percent Insiders -
Percent Institutions -

Analyst Ratings

Rating -
Target Price -
Buy -
Strong Buy -
Buy -
Strong Buy -
Hold -
Sell -
Strong Sell -
Strong Sell -

ai summary icon Upturn AI SWOT

Envoy Medical Inc.

stock logo

Company Overview

overview logo History and Background

Envoy Medical Inc., formerly known as Soundhawk Corporation, is a hearing health company focused on developing and commercializing innovative medical devices for hearing loss. Details about its exact founding date and early milestones are limited but it has evolved focusing on fully implanted hearing solutions.

business area logo Core Business Areas

  • Fully Implanted Hearing Solutions: Focuses on developing and marketing the Esteemu00ae fully implanted active middle ear implant. This includes surgical procedures, device maintenance, and audiological support.

leadership logo Leadership and Structure

The leadership team includes individuals with experience in medical device development and commercialization. Specifics about the full organizational structure are not publicly available.

Top Products and Market Share

overview logo Key Offerings

  • Esteemu00ae: The Esteemu00ae is a fully implanted active middle ear implant designed to provide natural sound quality and improved speech understanding. The company claims that it's the only fully implanted active middle ear implant approved by the FDA. It is difficult to determine the market share due to the nascent nature of the product. Competitors include companies focused on traditional hearing aids and cochlear implants.

Market Dynamics

industry overview logo Industry Overview

The hearing loss industry is growing, driven by an aging population and increased awareness of hearing health. The industry consists of hearing aid manufacturers, cochlear implant providers, and emerging companies with innovative solutions like fully implanted devices.

Positioning

Envoy Medical is positioned as an innovator with its fully implanted technology. This provides a potential advantage over traditional hearing aids and cochlear implants for certain patients due to its more natural sound experience and discreetness. However, it is a smaller company than the main competitors which present challenges in scaling production and distribution.

Total Addressable Market (TAM)

The global hearing aid market is estimated to be worth billions of dollars. Envoy Medical is targeting a subset of this market, specifically individuals with moderate to severe sensorineural hearing loss who are seeking a more discreet and natural-sounding solution. As market penetration for a novel medical technology, it is very low and is trying to increase adoption with an initial small amount of users.

Upturn SWOT Analysis

Strengths

  • Unique fully implanted hearing technology (Esteemu00ae)
  • FDA approved
  • Potential for improved sound quality and user experience compared to traditional hearing aids.

Weaknesses

  • Relatively small company
  • Limited market penetration
  • Dependence on a single product (Esteemu00ae)
  • High cost compared to traditional hearing aids
  • Requires specialized surgical expertise for implantation

Opportunities

  • Expanding market for hearing loss solutions
  • Increasing awareness of the benefits of fully implanted devices
  • Potential for partnerships with audiologists and ENT specialists
  • New product development and technological advancements

Threats

  • Competition from established hearing aid manufacturers
  • Reimbursement challenges from insurance providers
  • Technological advancements in competing hearing solutions
  • Economic downturn impacting consumer spending on healthcare

Competitors and Market Share

competitor logo Key Competitors

  • SONO
  • GN
  • WS Audiology (Private)

Competitive Landscape

Envoy Medical differentiates itself with its fully implanted design compared to traditional hearing aids. However, it faces significant competition from larger companies with established brands, distribution networks, and research and development resources.

Growth Trajectory and Initiatives

Historical Growth: Envoy Medical has focused on FDA approval and initial commercialization of the Esteem device. Significant revenue growth has not yet been achieved.

Future Projections: Future growth depends on the successful commercialization of the Esteem, increased market penetration, and expansion into new markets. Analyst estimates are not widely available due to limited coverage.

Recent Initiatives: Focus on expanding the availability of surgical training and increasing awareness among audiologists and patients.

Summary

Envoy Medical is a small, innovative company with a unique fully implanted hearing solution. Its strengths lie in its differentiated technology and potential for improved patient outcomes. However, it faces challenges related to commercialization, competition, and reimbursement. Significant revenue growth is needed for long-term success.

Peer Comparison

Sources and Disclaimers

Data Sources:

  • Envoy Medical Inc. website
  • FDA website
  • Market research reports (hearing aid industry)
  • Industry news articles
  • SEC filings

Disclaimers:

The information provided is for informational purposes only and should not be considered financial advice. Market share data is approximate. Investors should conduct their own due diligence before making any investment decisions.

Upturn AI SummarizationUpturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI SummarizationUpturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI SummarizationUpturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI SummarizationUpturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.

About Envoy Medical Inc.

Exchange NASDAQ
Headquaters White Bear Lake, MN, United States
IPO Launch date 2021-04-23
CEO & Director Mr. Brent T. Lucas Esq.
Sector Healthcare
Industry Medical Devices
Full time employees 42
Full time employees 42

Envoy Medical, Inc., a hearing health company, focuses on providing medical technologies across the hearing loss spectrum. The company's medical technologies are designed to shift the paradigm within the hearing industry and bring providers and patients the hearing devices desire. It offers personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc. in September 2023. Envoy Medical, Inc. was founded in 1995 and is headquartered in White Bear Lake, Minnesota.